Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy

HIGHLIGHTS

• who: Angiogenesis and collaborators from the were approved by the Bioethics Committee, Faculty of Medicine, University of ChileTumor growth assay have published the research work: Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy, in the Journal: (JOURNAL)
• what: The authors evaluate the angiogenic and antitumor effects of Cx in the development of a drug-resistant mammary adenocarcinoma (TA3-MTXR). The authors propose that Cx decreases growth in a drug resistant mammary adenocarcinoma tumor. The authors demonstrated that Celecoxib suppressed angiogenesis at 500 ppm and 1000 ppm. Although . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.